Literature for peptidase S60.001: lactoferrin

(Topics flags: S Structure, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2024
1. Ongena,R., Dierick,M., Vanrompay,D., Cox,E. and Devriendt,B.
   Lactoferrin impairs pathogen virulence through its proteolytic activity
   Front Vet Sci11, 1428156-1428156. PubMed  Europe PubMed DOI  V
2. Tanaka,M., Date,M. and Mizuno,K.
   New latex agglutination assay for the determination of lactoferrin in human milk
   Int Breastfeed J19, 74-74. PubMed  Europe PubMed DOI
2023
3. Alhumam,M.N., Alhumam,N. and Kandeel,M.
   The Antimicrobial Bifunctional Camel Lactoferrin: In Silico and Molecular Dynamic Perspective
   Biomed Res Int2023, 2322286-2322286. PubMed  Europe PubMed DOI
4. Dyrda-Terniuk,T. and Pomastowski,P.
   The Multifaceted Roles of Bovine Lactoferrin: Molecular Structure, Isolation Methods, Analytical Characteristics, and Biological Properties
   J Agric Food Chem71, 20500-20531. PubMed  Europe PubMed DOI
2020
5. Campione,E., Cosio,T., Rosa,L., Lanna,C., Di Girolamo,S., Gaziano,R., Valenti,P. and Bianchi,L.
   Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
   Int J Mol Sci21, PubMed  Europe PubMed DOI  V
6. Madadlou,A.
   Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2
   Eur J Pharmacol885, 173499-173499. PubMed  Europe PubMed DOI
2019
7. Soboleva,S.E., Sedykh,S.E., Alinovskaya,L.I., Buneva,V.N. and Nevinsky,G.A.
   Cow milk lactoferrin possesses several catalytic activities
   Biomolecules9, PubMed  Europe PubMed DOI
2016
8. Eipper,S., Steiner,R., Lesner,A., Sienczyk,M., Palesch,D., Halatsch,M.E., Zaczynska,E., Heim,C., Hartmann,M.D., Zimecki,M., Wirtz,C.R. and Burster,T.
   Lactoferrin is an allosteric enhancer of the proteolytic activity of cathepsin G
   PLoS ONE11, e0151509-e0151509. PubMed  Europe PubMed DOI
9. Giese,M., Turiello,N., Molenda,N., Palesch,D., Meid,A., Schroeder,R., Basilico,P., Benarafa,C., Halatsch,M.E., Zimecki,M., Westhoff,M.A., Wirtz,C.R. and Burster,T.
   Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells
   Oncotarget7, 74602-74611. PubMed  Europe PubMed DOI
2012
10. Plaut,A.G. and St Geme,J.W., III
    Lactoferrin
    [ISSN:978-0-12-407742-3]3, 3635-3640. DOI
2011
11. Piotukh,K., Geltinger,B., Heinrich,N., Gerth,F., Beyermann,M., Freund,C. and Schwarzer,D.
    Directed evolution of sortase A mutants with altered substrate selectivity profiles
    J Am Chem Soc133, 17536-17539. PubMed  Europe PubMed DOI
2010
12. Serruto,D., Spadafina,T., Ciucchi,L., Lewis,L.A., Ram,S., Tontini,M., Santini,L., Biolchi,A., Seib,K.L., Giuliani,M.M., Donnelly,J.J., Berti,F., Savino,S., Scarselli,M., Costantino,P., Kroll,J.S., O'Dwyer,C., Qiu,J., Plaut,A.G., Moxon,R., Rappuoli,R., Pizza,M. and Arico,B.
    Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
    Proc Natl Acad Sci U S A107, 3770-3775. PubMed  Europe PubMed DOI
2009
13. Baker,E.N. and Baker,H.M.
    A structural framework for understanding the multifunctional character of lactoferrin
    Biochimie91, 3-10. PubMed  Europe PubMed DOI  S
2008
14. Clarke,S.R. and Foster,S.J.
    IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin
    Infect Immun76, 1518-1526. PubMed  Europe PubMed DOI
15. Jacobsen,L.C., Sorensen,O.E., Cowland,J.B., Borregaard,N. and Theilgaard-Monch,K.
    The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils
    J Leukoc Biol83, 1155-1164. PubMed  Europe PubMed DOI
2005
16. Thomassen,E.A., van Veen,H.A., van Berkel,P.H., Nuijens,J.H. and Abrahams,J.P.
    The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin
    Transgenic Res14, 397-405. PubMed  Europe PubMed DOI  S
2004
17. Massucci,M.T., Giansanti,F., Di Nino,G., Turacchio,M., Giardi,M.F., Botti,D., Ippoliti,R., De Giulio,B., Siciliano,R., Donnarumma,G., Valenti,P., Bocedi,A., Polticelli,F., Ascenzi,P. and Antonini,G.
    Proteolytic activity of bovine lactoferrin
    Biometals17, 249-255. PubMed  Europe PubMed DOI
18. Ochoa,T.J. and Clearly,T.G.
    Lactoferrin disruption of bacterial type III secretion systems
    Biometals17, 257-260. PubMed  Europe PubMed DOI
19. Valenti,P., Berlutti,F., Conte,M.P., Longhi,C. and Seganti,L.
    Lactoferrin functions: current status and perspectives
    J Clin Gastroenterol38, S127-S129. PubMed  Europe PubMed
2003
20. Hendrixson,D.R., Qiu,J., Shewry,S.C., Fink,D.L., Petty,S., Baker,E.N., Plaut,A.G. and St Geme,J.W., III
    Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites
    Mol Microbiol47, 607-617. PubMed  Europe PubMed DOI
21. [YEAR:20-6-2003]Ohashi,A., Murata,E., Yamamoto,K., Majima,E., Sano,E., Le,Q.T. and Katunuma,N.
    New functions of lactoferrin and beta-casein in mammalian milk as cysteine protease inhibitors
    Biochem Biophys Res Commun306, 98-103. PubMed  Europe PubMed DOI
2002
22. Jameson,G.B., Anderson,B.F., Breyer,W.A., Day,C.L., Tweedie,J.W. and Baker,E.N.
    Structure of a domain-opened mutant (R121D) of the human lactoferrin N-lobe refined from a merohedrally twinned crystal form
    Acta Crystallogr D Biol Crystallogr58, 955-962. PubMed  Europe PubMed DOI  S
23. [YEAR:3-12-2002]Peterson,N.A., Arcus,V.L., Anderson,B.F., Tweedie,J.W., Jameson,G.B. and Baker,E.N.
    "Dilysine trigger" in transferrins probed by mutagenesis of lactoferrin: crystal structures of the R210G, R210E, and R210L mutants of human lactoferrin
    Biochemistry41, 14167-14175. PubMed  Europe PubMed DOI  S
2000
24. [YEAR:6-6-2000]Peterson,N.A., Anderson,B.F., Jameson,G.B., Tweedie,J.W. and Baker,E.N.
    Crystal structure and iron-binding properties of the R210K mutant of the N-lobe of human lactoferrin: implications for iron release from transferrins
    Biochemistry39, 6625-6633. PubMed  Europe PubMed DOI  S
25. [YEAR:8-12-2000]Plaut,A.G., Qiu,J. and St Geme,J.W., III
    Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae
    Vaccine19 Suppl 1, S148-S152. PubMed  Europe PubMed DOI
1999
26. Sun,X.L., Baker,H.M., Shewry,S.C., Jameson,G.B. and Baker,E.N.
    Structure of recombinant human lactoferrin expressed in Aspergillus awamori
    Acta Crystallogr D Biol Crystallogr55, 403-407. PubMed  Europe PubMed DOI  E  S
1998
27. Baker,E.N., Anderson,B.F., Baker,H.M., MacGillivray,R.T., Moore,S.A., Peterson,N.A., Shewry,S.C. and Tweedie,J.W.
    Three-dimensional structure of lactoferrin. Implications for function, including comparisons with transferrin
    Adv Exp Med Biol443, 1-14. PubMed  Europe PubMed  S
28. [YEAR:1-11-1998]Jameson,G.B., Anderson,B.F., Norris,G.E., Thomas,D.H. and Baker,E.N.
    Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change
    Acta Crystallogr D Biol Crystallogr54, 1319-1335. PubMed  Europe PubMed  S
1997
29. Elrod,K.C., Moore,W.R., Abraham,W.M. and Tanaka,R.D.
    Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep
    Am J Respir Crit Care Med156, 375-381. PubMed  Europe PubMed DOI
30. [YEAR:28-11-1997]Moore,S.A., Anderson,B.F., Groom,C.R., Haridas,M. and Baker,E.N.
    Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution
    J Mol Biol274, 222-236. PubMed  Europe PubMed DOI  S
31. [YEAR:14-1-1997]Nicholson,H., Anderson,B.F., Bland,T., Shewry,S.C., Tweedie,J.W. and Baker,E.N.
    Mutagenesis of the histidine ligand in human lactoferrin: iron binding properties and crystal structure of the histidine-253 - >methionine mutant
    Biochemistry36, 341-346. PubMed  Europe PubMed DOI  S
1996
32. Faber,H.R., Bland,T., Day,C.L., Norris,G.E., Tweedie,J.W. and Baker,E.N.
    Altered domain closure and iron binding in transferrins: the crystal structure of the Asp60Ser mutant of the amino-terminal half-molecule of human lactoferrin
    J Mol Biol256, 352-363. PubMed  Europe PubMed DOI  S
33. Faber,H.R., Baker,C.J., Day,C.L., Tweedie,J.W. and Baker,E.N.
    Mutation of arginine 121 in lactoferrin destabilizes iron binding by disruption of anion binding: crystal structures of R121S and R121E mutants
    Biochemistry35, 14473-14479. PubMed  Europe PubMed DOI  S
1994
34. Smith,C.A., Anderson,B.F., Baker,H.M. and Baker,E.N.
    Structure of copper- and oxalate-substituted human lactoferrin at 2.0 A resolution
    Acta Crystallogr D Biol Crystallogr50, 302-316. PubMed  Europe PubMed DOI  S
1993
35. Day,C.L., Anderson,B.F., Tweedie,J.W. and Baker,E.N.
    Structure of the recombinant N-terminal lobe of human lactoferrin at 2.0 A resolution
    J Mol Biol232, 1084-1100. PubMed  Europe PubMed DOI  S
1989
36. [YEAR:20-10-1989]Anderson,B.F., Baker,H.M., Norris,G.E., Rice,D.W. and Baker,E.N.
    Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution
    J Mol Biol209, 711-734. PubMed  Europe PubMed DOI  S
1987
37. Anderson,B.F., Baker,H.M., Dodson,E.J., Norris,G.E., Rumball,S.V., Waters,J.M. and Baker,E.N.
    Structure of human lactoferrin at 3.2-A resolution
    Proc Natl Acad Sci U S A84, 1769-1773. PubMed  Europe PubMed  S